QSAM Biosciences ROCE
Mi az QSAM Biosciences ROCE?
A ROCE az QSAM Biosciences, Inc. - 427.73%
Mi a ROCE meghatározása?
A befektetett tőke megtérülése (ROCE) olyan pénzügyi arány, amely a vállalat jövedelmezőségét és a tőke felhasználásának hatékonyságát méri.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE a Health Care szektor a OTC-on cégekben a QSAM Biosciences -hoz képest
Mit csinál QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
roce -hoz hasonló cégek QSAM Biosciences
- PAVmed Inc nak ROCE 411.68% van
- Q-Gold Resources nak ROCE 414.05% van
- LiteLink Technologies nak ROCE 414.08% van
- Empire Industries nak ROCE 418.52% van
- 102570 nak ROCE 421.84% van
- Capitan Mining nak ROCE 423.79% van
- QSAM Biosciences nak ROCE 427.73% van
- Mustang Bio Inc nak ROCE 433.01% van
- Sonoro Gold nak ROCE 434.69% van
- Nevtah Capital Management nak ROCE 448.86% van
- Richland Resources International nak ROCE 448.86% van
- Permian Basin Royalty Trust nak ROCE 457.43% van
- Navigator Acquisition nak ROCE 463.12% van